FSA
Franklin Street Advisors Portfolio holdings
AUM
$1.61B
This Quarter Return
-0.23%
1 Year Return
+24.37%
3 Year Return
+112.05%
5 Year Return
+186.1%
10 Year Return
+475.68%
AUM
$506M
AUM Growth
+$506M
(-0.51%)
Cap. Flow
+$7.72M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
27.46%
Holding
257
New
22
Increased
93
Reduced
70
Closed
26
Top Buys
| 1 |
Southern Company
SO
|
$3.86M |
| 2 |
HAR
Harman International Industries
HAR
|
$3.8M |
| 3 |
Starbucks
SBUX
|
$3.75M |
| 4 |
Procter & Gamble
PG
|
$3.33M |
| 5 |
Amazon
AMZN
|
$3.22M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$5.8M |
| 2 |
eBay
EBAY
|
$5.64M |
| 3 |
Ecolab
ECL
|
$4.4M |
| 4 |
Thomson Reuters
TRI
|
$3.49M |
| 5 |
Thermo Fisher Scientific
TMO
|
$2.62M |
Sector Composition
| 1 | Healthcare | 22.22% |
| 2 | Technology | 17.08% |
| 3 | Financials | 13.92% |
| 4 | Industrials | 9.99% |
| 5 | Consumer Discretionary | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pfizer
PFE
$141B
| $1.16M | 0.23% | 39,182 +6,698 | +21% | +$198K |
|
102
Meta Platforms (Facebook)
META
$1.86T
| $1.09M | 0.21% | 9,505 +7,475 | +368% | +$853K |
|
103
Intel
INTC
$107B
| $1.05M | 0.21% | 32,326 +3,912 | +14% | +$127K |
|
|
ITCI
104
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $972K | 0.19% | 34,950 +2,475 | +8% | +$68.8K |
|
105
Puma Biotechnology
PBYI
$254M
| $971K | 0.19% | 33,045 +18,300 | +124% | +$538K |
|
|
DD
106
DELISTED
Du Pont De Nemours E I
DD
| $969K | 0.19% | 15,297 -80 | -0.5% | -$5.07K |
|
|
SHPG
107
DELISTED
Shire pic
SHPG
| $945K | 0.19% | 5,500 | – | – |
|
108
Jazz Pharmaceuticals
JAZZ
$7.75B
| $933K | 0.18% | 7,150 | – | – |
|
109
Truist Financial
TFC
$60.4B
| $925K | 0.18% | 27,790 | – | – |
|
110
Kinder Morgan
KMI
$60B
| $912K | 0.18% | +51,084 | New | +$912K |
|
|
CEMP
111
DELISTED
Cempra, Inc.
CEMP
| $905K | 0.18% | 51,650 +44,000 | +575% | +$771K |
|
112
JPMorgan Chase
JPM
$829B
| $820K | 0.16% | 13,848 +1,625 | +13% | +$96.2K |
|
113
Insmed
INSM
$28.8B
| $796K | 0.16% | 62,829 +2,500 | +4% | +$31.7K |
|
114
General Dynamics
GD
$87.3B
| $780K | 0.15% | 5,940 | – | – |
|
115
General Motors
GM
$55.8B
| $773K | 0.15% | 24,597 +3,277 | +15% | +$103K |
|
116
Bank of America
BAC
$376B
| $760K | 0.15% | 56,214 -3,000 | -5% | -$40.6K |
|
117
Ultragenyx Pharmaceutical
RARE
$2.89B
| $724K | 0.14% | 11,435 -20 | -0.2% | -$1.27K |
|
|
QLTI
118
DELISTED
QLT Inc
QLTI
| $716K | 0.14% | 360,000 -9,200 | -2% | -$18.3K |
|
119
Xencor
XNCR
$580M
| $711K | 0.14% | 53,000 | – | – |
|
|
VCRA
120
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $704K | 0.14% | 55,200 -15,850 | -22% | -$202K |
|
121
Costco
COST
$418B
| $686K | 0.14% | 4,355 +1,840 | +73% | +$290K |
|
122
Pacira BioSciences
PCRX
$1.2B
| $653K | 0.13% | 12,325 +6,125 | +99% | +$325K |
|
|
CELG
123
DELISTED
Celgene Corp
CELG
| $651K | 0.13% | 6,509 -12,380 | -66% | -$1.24M |
|
124
Philip Morris
PM
$260B
| $646K | 0.13% | 6,582 -185 | -3% | -$18.2K |
|
125
FibroGen
FGEN
$47.8M
| $639K | 0.13% | 30,000 +10,000 | +50% | +$213K |
|